Autor: |
Piotrowski, Dariusz, Baluta-Przybylska, Zofia, Ciszewska, Krystyna, Szczepański, Mariusz, Picard-Maureau, Marcus |
Předmět: |
|
Zdroj: |
Acta Haematologica Polonica; 2022, Vol. 53 Issue A, p103-104, 2p |
Abstrakt: |
Introduction: During the COVID-19 pandemic strict measures to ensure social distancing were introduced according to pandemic wave progression, especially in 2020. The hospitals were instructed to reduce routine surgery and treatment and increase COVID-19 patients treatment capacities, impacting blood product availability and demand. Aims: To assess the impact of the COVID-19 pandemic on blood donation, component preparation, demand and procedures in the WRBTC. Material and methods: Data about blood product collections and component production from the WRBTC during 2020 and 2021 were analyzed and compared to each other and to 2019 pre-pandemic data as well as in relation to pandemic waves in Poland and COVID-19 control as per regulations. Results: The number of WB donations dropped 8.7% in 2020 compared to 2019. Most impactful in April (5868) and November (7487) compared to the average number of donations per month (8226.4 ± 1166.5) in that year, correlating with strict measures to ensure social distancing. The demand for RBCs and PCs decreased as well. The total number of RBCs produced in 2020 was reduced 9.8% compared to 2019, the number of PCs 17.8%. In 2021 RBCs reached 2019 levels, while PCs were still 10% lower. A shift from 8.9% apheresis FFP in 2019 to 1.8% in 2020 and 1.3% in 2021 was observed. PR-FFP increased from 26.6% of FFP issued units in 2019 to 41.5% in 2020 and 57% in 2021. Conclusions: Decreased donations and decreased demand during the first 2 waves of COVID-19 due to shifting hospital clinical practice led to decreased production and demand in 2020, but not in 2021. Changes in donor availability and introduction of CCP collection led to a shift from AP-FFP to WB-FFP. The need for increased flexibility resulted in the decision to nearly double the rate of PR-treated FFP units optimizing blood supply chain management. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|